“Racial/ethnic Differences In Clinical Trial Enrollment, Refusal Rates, Ineligibility, And Reasons For Decline Among Patients At Sites In The National Cancer Institute's Community Cancer Centers Program.”. Cancer 120 (6). Cancer: 877-84. doi:10.1002/cncr.28483.
. 2014. “Use Of The National Cancer Institute Community Cancer Centers Program Screening And Accrual Log To Address Cancer Clinical Trial Accrual.”. J Oncol Pract 10 (2). J Oncol Pract: e73-80. doi:10.1200/JOP.2013.001194.
. 2014. “Early-Phase Clinical Trials In The Community: Results From The National Cancer Institute Community Cancer Centers Program Early-Phase Working Group Baseline Assessment.”. J Oncol Pract 9 (2). J Oncol Pract: e55-61. doi:10.1200/JOP.2012.000695.
. 2013. “An International Ki67 Reproducibility Study.”. J Natl Cancer Inst 105 (24). J Natl Cancer Inst: 1897-906. doi:10.1093/jnci/djt306.
. 2013. “The National Cancer Institute-American Society Of Clinical Oncology Cancer Trial Accrual Symposium: Summary And Recommendations.”. J Oncol Pract 9 (6). J Oncol Pract: 267-76. doi:10.1200/JOP.2013.001119.
. 2013. “Recommendations For Collection And Handling Of Specimens From Group Breast Cancer Clinical Trials.”. J Clin Oncol 26 (34). J Clin Oncol: 5638-44. doi:10.1200/JCO.2007.15.1712.
. 2008. “Proposal For Standardized Definitions For Efficacy End Points In Adjuvant Breast Cancer Trials: The Steep System.”. J Clin Oncol 25 (15). J Clin Oncol: 2127-32. doi:10.1200/JCO.2006.10.3523.
. 2007. “Clinical Trials Referral Resource. Current Phase Iii Breast Cancer Clinical Trials.”. Oncology (Williston Park) 20 (7). Oncology (Williston Park): 696, 700, 702.
. 2006. “Clinical Trials Referral Resource. Current Phase Iii, Nci-Supported, Cooperative Group Clinical Trials In Breast Cancer.”. Oncology (Williston Park) 18 (4). Oncology (Williston Park): 463-4, 467-8, 470.
. 2004. “Pediatric Transplantation Of The Kidney, Liver And Heart: Summary Report.”. Pediatr Transplant 8 (1). Pediatr Transplant: 75-86. doi:10.1111/j.1399-3046.2004.2s050.x.
. 2004. “Clinical Trials Referral Resource. Targeted Therapy In Squamous Cell Cancers Of The Head And Neck.”. Oncology (Williston Park) 16 (5). Oncology (Williston Park): 621-2, 625-6.
. 2002.